Your browser doesn't support javascript.
loading
A transcriptomic and proteomic atlas of obesity and type 2 diabetes in cynomolgus monkeys.
Zhang, Xianglong; Hu, Liangbiao George; Lei, Ying; Stolina, Marina; Homann, Oliver; Wang, Songli; Véniant, Murielle M; Hsu, Yi-Hsiang.
Afiliação
  • Zhang X; Center for Research Acceleration by Digital Innovation (CRADI), Amgen Research, South San Francisco, CA 94080, USA.
  • Hu LG; Research China, Amgen Research, Shanghai 200020, China. Electronic address: liangbiaohu8@gmail.com.
  • Lei Y; Research China, Amgen Research, Shanghai 200020, China.
  • Stolina M; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA 91320, USA.
  • Homann O; Center for Research Acceleration by Digital Innovation (CRADI), Amgen Research, South San Francisco, CA 94080, USA.
  • Wang S; Research Biomics, Amgen Research, South San Francisco, CA 94080, USA.
  • Véniant MM; Department of Cardiometabolic Disorders, Amgen Research, Thousand Oaks, CA 91320, USA. Electronic address: mveniant@amgen.com.
  • Hsu YH; Marcus Institute for Aging Research and Harvard Medical School, Boston, MA 02131, USA. Electronic address: yihsianghsu@hsl.harvard.edu.
Cell Rep ; 42(8): 112952, 2023 08 29.
Article em En | MEDLINE | ID: mdl-37556324
Obesity and type 2 diabetes (T2D) remain major global healthcare challenges, and developing therapeutics necessitates using nonhuman primate models. Here, we present a transcriptomic and proteomic atlas of all the major organs of cynomolgus monkeys with spontaneous obesity or T2D in comparison to healthy controls. Molecular changes occur predominantly in the adipose tissues of individuals with obesity, while extensive expression perturbations among T2D individuals are observed in many tissues such as the liver and kidney. Immune-response-related pathways are upregulated in obesity and T2D, whereas metabolism and mitochondrial pathways are downregulated. Moreover, we highlight some potential therapeutic targets, including SLC2A1 and PCSK1 in obesity as well as SLC30A8 and SLC2A2 in T2D. Our study provides a resource for exploring the complex molecular mechanism of obesity and T2D and developing therapies for these diseases, with limitations including lack of hypothalamus, isolated islets of Langerhans, longitudinal data, and body fat percentage.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article